Sorbie Bornholm LP
  • The Sorbie-Strategy
  • Our Team
  • News
  • Locations
    • Australia
    • United Kingdom
    • United States
  • Contact Us
Select Page

Neuren Pharmaceuticals bags A$11.5M to progress Rett syndrome trials

by Editorial Staff | Jun 29, 2017 | News Release

Placement anchored by A$10 million from UK fund Neuren Pharmaceuticals (ASX:NEU) has secured a funding of A$11.5 million via the placement of shares at $0.062 each, to enable the initiation of key activities for commencing a Phase 3 trial in Rett syndrome. Neuren is...

Recent Posts

  • Sorbie Bornholm Announces Tocvan Ventures Corp. Received Approximately 18% Additional Cash from the Sharing Agreement
  • Sorbie Bornholm Announces New Investment in Ares Strategic Mining Inc.
  • Sorbie Bornholm Announces Tocvan Ventures Corp. Received Nearly 14% Additional Cash from the Sharing Agreement
  • Sorbie Bornholm Announces Tocvan Ventures Corp. Received Nearly 23% Additional Cash from the Sharing Agreement
  • Greg Kofford to Speak at Mines and Money Miami

Archives

  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • February 2024
  • October 2023
  • June 2023
  • April 2023
  • July 2022
  • April 2022
  • March 2022
  • March 2021
  • February 2021
  • November 2019
  • May 2018
  • October 2017
  • June 2017
  • Follow
  • Follow
  • Follow
  • Follow

Sorbie-Strategy  Our Team  News  Contact Us

Terms of Use  Privacy Policy

Copyright © 2024 Sorbie Bornholm LP | All Rights Reserved